International Immunology, Vol. 16, No. 1, pp. 23-32,
January 2004
© 2004 Japanese Society for Immunology
Differential regulation of NK cell proliferation by type I and type II IFN
1 Department of Microbiology and Immunology, Kimmel Cancer Center, Jefferson Medical College, Philadelphia, PA 19107, USA
Correspondence to: B. Perussia; E-mail: Bice.Perussia{at}mail.tju.edu
Transmitting editor: R. Schreiber
IFN, produced during viral infections by accessory (type I IFN) or NK cells (type II IFN), play a primary role in the regulation of immune and anti-viral NK cell effector functions. Because IFN have anti-proliferative effects on several cell types, including hematopoietic cells, we asked whether they modulate proliferation of human NK cells, and whether IFN-
and IFN-
mediate distinct effects on NK cells at different developmental stages. Analysis of proliferation at the single-cell level in human NK cells indicated that both IFN types inhibit IL-4-induced accumulation of immature CD56 IL-13+ NK cells in freshly separated peripheral blood lymphocytes and in cells derived from them after short-term cultures. However, IFN-
inhibited specifically the IL-4-dependent proliferation of these cells without affecting the IL-2-dependent one or that of the IL-13 cells, whereas IFN-
attenuated proliferation of NK cells at any developmental stage (both immature CD56IL-13+ and mature CD56+IL-13 IFN-
+ NK cells) and contributed to their monokine-induced differentiation to IFN-
-producing cells. Adding to our previous report that IL-13 inhibits accumulation of mature IFN-
+ NK cells, the present data unravel a mechanism by which peripheral immature IL-13+ and mature IFN-
+ NK cells can negatively regulate each others accumulation.
Keywords: cytokine, NK cell development
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. J. Loza, P. Luppi, K. Kiefer, E. S. Martin, J. L. Szczytkowski, and B. Perussia Human peripheral CD2-/lo T cells: an extrathymic population of early differentiated, developing T cells Int. Immunol., September 1, 2005; 17(9): 1213 - 1225. [Abstract] [Full Text] [PDF] |
||||
